Pioneering Dengue Vaccine PRAHR Wins Top Innovation Award at GBU-Biothon 2025

A revolutionary breakthrough in dengue prevention has emerged as the T-cell based vaccine PRAHR bagged the Best Innovation Award at the GBU-Biothon 2025. Developed by a team at Gujarat Biotechnology University, this innovative vaccine uses T cell receptors to target and eliminate dengue-infected cells, thus minimizing risks associated with traditional vaccines. This pioneering approach addresses dengue, one of the most serious health threats in tropical regions, and it holds promise for even broader applications in combating diseases such as cancer. The future of immunization is bright, with PRAHR at the forefront.

 

Source: Indian Express